| 库欣病的分子机制及靶向药物 |
| |
| 引用本文： | 辅容,卢琳,龚凤英,潘慧,朱慧娟,陆召麟. 库欣病的分子机制及靶向药物[J]. 国际内分泌代谢杂志, 2016, 0(6): 400-403. DOI: 10.3760/cma.j.issn.1673-4157.2016.06.11 |
| |
| 作者姓名： | 辅容 卢琳 龚凤英 潘慧 朱慧娟 陆召麟 |
| |
| 作者单位： | 100730北京,中国医学科学院,北京协和医学院,北京协和医院内分泌科,国家卫生和计划生育委员会内分泌重点实验室 |
| |
| 基金项目： | 中华医学会临床医学科研专项资金-下丘脑垂体研究项目(13050940479)，国家临床重点专科基金(WBYZ2011-873)The Hypothalamic-Pituitary Research Project |
| |
| 摘 要： | 由垂体瘤分泌过多的促肾上腺皮质激素导致的库欣综合征,又称为库欣病,首选治疗为手术治疗,放射治疗和药物治疗为其辅助治疗,但疗效均有限.近年来关于库欣病发病机制的研究集中于调控细胞增殖的异常蛋白表达和调控激素分泌的异常信号转导,靶点主要为表皮生长因子受体(EGFR)、细胞周期蛋白E(CDK2/Cyclin E)和热休克蛋白90(HSP90),相应的靶向药物吉非替尼、roscovitine和水飞蓟素均能有效减小肿瘤体积,降低促肾上腺皮质激素水平.
|
| 关 键 词： | 促肾上腺皮质激素分泌垂体腺瘤 靶向治疗 表皮生长因子 细胞周期蛋白依赖激酶2 热休克蛋白90 |
Molecular mechanisms of Cushing's disease and targeted drug |
| |
| Abstract: | Cushing's disease,also called Cushing's syndrome is due to excessive secretion of adrenocorticotropin hormone (ACTH) caused by pituitary adenoma.Surgery is recommended as the first-line therapy,while radiotherapy and medicine are adjunctive therapies.But effects of these therapies are limited.Recently,the studies on the pathogenesis of Cushing'sdisease have focused on the abnormal protein expressions of cell proliferation and dysregulated signal transductions of hormone secretion.Targets includes epidermal growth factor receptor,cyclin-dependent kinase 2/Cyclin E and heat-shock protein 90.Corresponding targeted drugs such as gefitinib,roscovitine,silibinin are proven to be effective to reduce the volume of the tumor and the level of ACTH. |
| |
| Keywords: | Adrenocorticotropin hormonesecreting pituitary adenoma Targeted therapy Epidermal growth factor Cyclin-dependent kinase 2 Heat-shock protein 90 |
| 本文献已被 万方数据 等数据库收录！ |
|
